Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "Nature"

202 News Found

Study details Proof-of-Concept for Covid-19 detection via saliva screening
Medical Device | February 24, 2022

Study details Proof-of-Concept for Covid-19 detection via saliva screening

Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR


Experts point out key issues for vision loss at ASSOCHAM meet
Healthcare | February 24, 2022

Experts point out key issues for vision loss at ASSOCHAM meet

Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes


BDR plans to enter the regulated markets this year: Raheel Shah, Director, BDR Group of Companies
interviews | February 15, 2022

BDR plans to enter the regulated markets this year: Raheel Shah, Director, BDR Group of Companies

BDR Pharmaceuticals is a home-grown company with operations in India and overseas. It’s known for its formulations portfolio and has a presence in specialty medicines. The company has ambitious plans as it has ramped up capacity and looking to foray into regulated markets. Raheel Shah, Director, BDR Group of Companies shares his insights in an interview with Thomas C Thottathil, Editor, Indian Pharma Post


C2i Genomics Partners with Twist Bioscience for cancer detection
Biotech | February 09, 2022

C2i Genomics Partners with Twist Bioscience for cancer detection

Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe


Lupin signs distribution agreement with Medis for Orphan Drug NaMuscla@
News | February 09, 2022

Lupin signs distribution agreement with Medis for Orphan Drug NaMuscla@

NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction


Lonza partners with biotech firm HaemaLogiX on multiple myeloma drug candidate
Biotech | January 29, 2022

Lonza partners with biotech firm HaemaLogiX on multiple myeloma drug candidate

Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China


FDC’s chooses UFlex’ Asepto holographic packaging for Electral
Packaging | January 25, 2022

FDC’s chooses UFlex’ Asepto holographic packaging for Electral

The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid


Australia grants provisional registration for Novavax Covid-19 vaccine
Drug Approval | January 20, 2022

Australia grants provisional registration for Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia


Bayer and Mammoth Biosciences to collaborate on gene editing technology
Biotech | January 10, 2022

Bayer and Mammoth Biosciences to collaborate on gene editing technology

Under the terms of the agreement, Mammoth Biosciences will receive an upfront payment of USD 40 million, potential future payments of more than one billion USD upon successful achievement of certain research, development, and commercial milestones


ENTOD Pharmaceuticals set to launch Molentod
News | January 06, 2022

ENTOD Pharmaceuticals set to launch Molentod

It is the generic version of molnupiravir